ArticleHeadache

Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab.

Victoria Nikitina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.